News Feed

Corporate June 09, 2017 01:00

By The Nation


Qiagen, a pharmaceutical research company based in Germany, yesterday announced its expansion in Thailand and opened an office in Bangkok to enhance relationships with life-science researchers and healthcare providers in this growing market.

Qiagen also announced two new collaborations in Thailand: a molecular techniques centre established with the faculty for tropical medicine at Mahidol University, and a collaboration with Ramathibodi Hospital to study genomic insights from next-generation sequencing (NGS).

“We are pleased to expand our commitment to the people of Thailand, where we have built relationships with medical institutions and the government for more than 16 years,” said William Lin, director of commercial operations for Qiagen Thailand. “

The collaboration with Mahidol University has established the Qiagen-TropMed Centre for Molecular Techniques in conjunction with the faculty of tropical medicine to support research using molecular biology techniques.

Qiagen has also joined with the Medical Genomic Centre at Ramathibodi Hospital in Bangkok to help guide personalised healthcare treatment decisions using Qiagen NGS solutions.